Motley Fool Premium
  1. Stocks
    2. /
  2. Moderna, Inc. (NASDAQ: MRNA)
    3. /

NASDAQ:MRNA (Moderna, Inc.)

About MRNA

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Moderna, Inc. (NASDAQ: MRNA) Latest News

Syringe and vial on blue background
Investing Articles

Is it time to buy Moderna shares?

| Dr. James Fox

Moderna shares have lost nearly 15% of their value over the last week. So is it time for me to…

Read more »

Investing Articles

Is Moderna stock a buy?

| Dan Appleby, CFA

Moderna stock is rallying after a new strain of the Covid virus was announced. Dan Appleby looks at the company…

Read more »

Investing Articles

What is the Moderna share price really worth?

| Rupert Hargreaves

Rupert Hargreaves explains why he thinks the Moderna share price is attractively priced after the company's recent declines.

Read more »

Investing Articles

I think these 2 S&P 500 stocks are severely overvalued

| Stuart Blair

S&P 500 stocks have soared in recent times, reaching new highs day-by-day. But I now think that these two growth…

Read more »

Young lady working from home office during coronavirus pandemic.
Investing Articles

Should I buy Moderna for my Stocks and Shares ISA?

| Rupert Hargreaves

Rupert Hargreaves explains why he thinks the Moderna share price could be an attractive acquisition for his Stocks and Shares…

Read more »

Syringe and vial on blue background
Investing Articles

Moderna shares are beating the rest of the S&P 500. Am I buying?

| Stuart Blair

Moderna shares have had a fantastic 2021, and have risen far more than the rest of the S&P 500. After…

Read more »

Investing Articles

Can the Moderna share price keep rising?

| Zaven Boyrazian, MSc

The Moderna share price has surged more than 450% in 12 months. But this explosive growth may soon be over.…

Read more »

Investing Articles

The Moderna share price has risen +400%: should I buy the stock now?

| Charlie Keough

With the continued vaccine rollout leading to a positive Q1, Charlie Keough assesses whether he sees long-term value in the…

Read more »

Investing Articles

The Moderna share price: have I missed the boat?

| Jon Smith

After rallying over 300% in the past year, Jonathan Smith offers his opinion on whether the Moderna share price still…

Read more »

Syringe and vial on blue background
Investing Articles

The AstraZeneca share price steadies: is this FTSE 100 stock a good investment?

| Kirsteen Mackay

The AstraZeneca share price is showing resilience in the face of disappointing vaccine publicity. This FTSE 100 stock has a…

Read more »